ALNYLAM PHARMA (NASDAQ:ALNY)

16.84

0.02 (0.12%)

ALNYLAM PHARMA (NASDAQ:ALNY) Delayed :
Previous Close	$16.86	52 Week High	$26.36
Open	$16.80	52 Week Low	$14.82
Day High	$17.04	P/E	N/A
Day Low	$16.74	EPS	$-1.19
Volume	137,147
More ALNY Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
ISIS	6	AVII	2
CBST	2	VICL	2
LMNX	2	NVS	2
CVM	1	AHT	1
CLH	1	EQY	1
HEES	1	LLNW	1

View All Entities

Nov 4, 2009 04:53 PM Alnylam Pharma (ALNY) Posts Q3 adj.-Loss of $0.23, Beats by 1c
Aug 6, 2009 04:24 PM Alnylam Pharmaceuticals (ALNY) Reports Large Q2 Loss; Comments on Outlook
Feb 24, 2009 04:04 PM Alnylam Pharma (ALNY) Reports Q4 Loss of $0.23, Misses by 8c

Nov 12, 2009 07:30 AM Alnylam Pharma (ALNY) To Provide RNAi Pipeline, Platform, and Tech Update at R&D Day in NY
Nov 4, 2009 04:53 PM Alnylam Pharma (ALNY) Posts Q3 adj.-Loss of $0.23, Beats by 1c
Nov 4, 2009 09:11 AM Alnylam Pharma (ALNY) Advances to RNAi Landmark Stage of Landmark Roche Alliance
Nov 3, 2009 01:42 PM Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
Nov 2, 2009 08:25 AM Alnylam Pharma (ALNY) Presentes Pre-Clinical TTR-ATTR Research Findings

Nov 18, 2009 07:00AM Alnylam Presents New Pre-clinical Data on ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer
Nov 12, 2009 07:00AM Alnylam Provides Update on RNAi Pipeline, Platform, and Technology at Its R&D Day
Nov 9, 2009 09:27AM Alnylam to Webcast R&D Day on Thursday, November 12, 2009
Nov 5, 2009 07:00AM Alnylam Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society (OTS) Meeting
Nov 4, 2009 04:00PM Alnylam Pharmaceuticals Reports Third Quarter 2009 Financial Results

Nov 18, 2009 04:41 PM Biotech Stocks for a Possible Year-End Rally
Aug 19, 2009 03:10 PM 38 Reasons the Google IPO Isn't as Big a Deal as Some Are Making It Out to Be
Jun 10, 2009 11:30 AM Analyst upgrades, downgrades and initiations: BP, DB, NUE, TLB, X, YHOO ...
Jun 9, 2009 03:47 AM Bio Medical Stock Sector is Where the Action Is
May 3, 2009 05:10 AM More on China Biotech Deals: M&A Numbers Misleading

Tony C
on Apr 28, 2009
at 09:13 AM money makers that will save- prolong life provectus pharma pvct another cancer cure +++ dandrion DNDN jump on board
Article: U.S. Issues Public Health Emergency About Swine Flu
natalia
on Apr 27, 2009
at 10:40 PM i see what you mean that stock finished up over 18% for the day on big volume. that's a much bigger gain than most of those stocks mentioned by hot list - and it was much higher earlier in the day. http://cxa.marketwatch.com/tsx/en/market/quote.aspx?symbol=rbm
Article: U.S. Issues Public Health Emergency About Swine Flu
Peter H
on Apr 27, 2009
at 10:16 PM 3M Rapid Detection Flu A+B Test I am surprised that this article didn't mention Response Biomedical (TSX: RBM), which makes the rapid flu test marketed by 3M as the 3M Rapid Detection Flu A + B Test. It was just launched in the fall and is a more accurate and sophisticated test than the other point of care tests on the market, like Quidel. By the way, RBM is also partnered with Roche (maker of Tamiflu) in an agreement to supply all of Roche's point of care cardiology tests and Cardiac Readers, which just launched in March of April.
Article: U.S. Issues Public Health Emergency About Swine Flu
Mike
on Mar 3, 2008
at 10:46 AM Suges I love it when a ticker "SUGES".
Article: Pre-Open Movers: Diebold (DBD) Surges On Takeover Bid, Thornburg Mortgage (TMA) Falls On Margin Calls

No comments are currently available.